2nd edition. There have been many requests over the past few years for advice about what information should be included in a patient record for leprosy. The patient record should contain the essential information for the clinical management of the patients, for monitoring adherence to MDT, and for r...eporting to the national programmes and to WHO. Patient records vary between countries due to differences in health systems and are modified from time to time. The Model Patient Record is recommended as a reference and as a check list when evaluating programmes and when reviewing existing patient records.
more
BMC Psychiatry 2014 14:191 https://doi.org/10.1186/1471-244X-14-191
Anxiety Disorders
Chapter F.4
Epilepsia, 55(4):475–482, 2014
doi: 10.1111/epi.12550
Assessing the impact of the EVD outbreak on health systems in Sierra Leone. Survey concluded 6-17 October 2014
To Initiating a Maternal, Neonatal and Child Health Project in Urban Slums with Social Mapping, Census Taking, and Community Engagement
Developmental disorders
Chapter C.2
2014 Edition
Psychiatry and Pediatrics
Chapter I.4
India AIDS Response Report 2014
« Programme Renforcement et Décentralisation de la Prévention et de
la prise en charge des PVVIH en RCA »
Nosocomial infections, or hospital-acquired infec-tions (HAI), are among the most significant causesof morbidity and mortality in healthcare settingsthroughout the world.Prevention of HAIs iscentral to providing high quality and safe health-care, even in settings with limited resources.Transmi...ssion of infectious agents between patientsby health workers and irrational use of antibioticsare two important preventable factors involved inmany HAIs.
more
Licensed pharmaceutical products (marketing authorization) should be manufactured only by licensed manufacturers (holders of a manufacturing authorization) whose activities are regularly inspected by competent national authorities. This guide to GMP shall be used as a standard to justify GMP status,... which constitutes one of the elements of the WHO Certification Scheme on the quality of pharmaceutical products moving in international commerce, through the assessment of applications for manufacturing authorizations and as a basis for the inspection of manufacturing facilities. It may also be used as training material for government medicines inspectors, as well as for production, QC and QA personnel in the industry
more